MedPath

Bone remodelling and density of the pelvis following implantation of the delta TT acetabular cup in patients undergoing primary total hip replacement for hip arthritis

Phase 4
Completed
Conditions
Hip replacement
Musculoskeletal - Osteoarthritis
Registration Number
ACTRN12619000003178
Lead Sponsor
IMA Orthopeadics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
47
Inclusion Criteria

Patients with rheumatoid or osteoarthritis of the hip who are candidates for a primary total hip replacement.

Exclusion Criteria

Patients with active infection, acute hip fracture, Patients who have had previous hip surgery. Patients with presence of malignancy in the hip joint area. Patient having surgery with other types of components. Patients who are mentally incompetent or unlikely to be compliant with the prescribed follow up evaluation schedule. Patients greater 125kg. Patients with a neuromuscular or concurrent illness which may affect their outcome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change in bone mineral density due to bone remodelling behind the acetabular component measured with DEXA scans to the hip & pelvis at various intervals over two years. [DEXA scans were performed at six weeks, six months, one year and two years after surgery]
Secondary Outcome Measures
NameTimeMethod
Clinical review (assessment of complications and revision surgery) [At six weeks, six months, one year and two years after surgery];Hip pain at rest assessed using a 100mm Visual Analogue Scale (VAS)[At six weeks, six months, one year and two years after surgery];Hip function and pain assessed using Oxford Hip Score (composite outcome)[At six weeks, six months, one year and two years after surgery];Hip pain at mobilisation assessed using a 100mm Visual Analogue Scale (VAS)[At six weeks, six months, one year and two years after surgery]
© Copyright 2025. All Rights Reserved by MedPath